Tumor-specific activation of prodrugs: Is there a role for nuclear medicine?

Research output: Contribution to journalEditorialAcademicpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)845-846
Number of pages2
JournalNuclear Medicine Communications
Volume29
Issue number10
DOIs
Publication statusPublished - Oct-2008

Keywords

  • PRONOUNCED ANTITUMOR EFFICACY
  • BETA-GLUCURONIDASE
  • ANTICANCER PRODRUGS
  • GENE-THERAPY
  • ENZYME
  • CANCER
  • DOXORUBICIN
  • PET

Cite this